Trade GMED anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
GLOBUS MEDICAL INC (GMED) is trading at US$82.56, up 0.02% today as of Aug 28, 12:28 EDT. The company has a market capitalisation of US$11.67B. Over the past 52 weeks, GMED has traded between US$54.15 and US$101.40. On Syfe you can trade GMED with $0 commission and add it to your watchlist.
| Previous close | US$82.54 |
|---|---|
| Market cap | US$11.67B |
| P/E ratio | 15.74 |
| 52-week range | US$54.15 – US$101.40 |
| Volume | 845.98K |
| Exchange | US |
Add to Watchlist
Set Price Alert
GLOBUS MEDICAL INC
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. It engages in developing products that promote healing in patients with musculoskeletal disorders. The firm classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul, David D. Davidar and Andrew Iott in 2003 and is headquartered in Audubon, PA.
Year: 2012
GLOBUS MEDICAL INC (GMED) stock is trading at US$82.56, +0.02% from the previous close of US$82.54.
The market cap for GLOBUS MEDICAL INC (GMED) stock is approximately US$11.67B.
The price-to-earnings ratio for GLOBUS MEDICAL INC (GMED) is 15.74, based on the latest reported earnings.
The 52-week high for GLOBUS MEDICAL INC (GMED) stock is US$101.40.
The 52-week low for GLOBUS MEDICAL INC (GMED) stock is US$54.15.
GLOBUS MEDICAL INC (GMED) does not currently pay a dividend.
Stay on top of GMED
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
